Rare Diseases
Conference Coverage
A case of neutrophilic eccrine hidradenitis attributed to HIV treatment
The most common causes of NEH are hematologic malignancies and some of the chemotherapeutic agents used in treating them.
News
First case of COVID-19 presenting as Guillain-Barré reported
A case report from China suggests a possible association between GBS and SARS-CoV-2 infection.
Conference Coverage
When to suspect calciphylaxis and what to do about it
Calciphylaxis is a skin condition with no generally accepted diagnostic criteria clinically, radiographically, or histologically.
Original Research
Is There an Association Between Hidradenitis Suppurativa and Fibromyalgia?
Although fibromyalgia does not occur more frequently in hidradenitis suppurativa (HS) patients, it is important to recognize that HS patients can...
Case Letter
An Unusual Presentation of Calciphylaxis
Although it commonly presents as well-demarcated, painful, purplish lesions that evolve into necrotic eschars, calciphylaxis rarely can present...
Latest News
Dermatology therapies evolve as disease knowledge and investment grow
There was a time when “almost every drug was more or less a hand-me-down” developed first for cancer or other diseases.
Conference Coverage
Testing times for epidermolysis bullosa topical therapies
LONDON – A number of trials have tested various topical therapies for EB, but none so far has produce the data needed to gain regulatory approval...
Conference Coverage
Merkel cell carcinoma management undergoes revolution
LAHAINA, HAWAII – “There are really important prognostic and therapeutic implications for a baseline scan in almost any patient with early Merkel...
Conference Coverage
Breaking bacterial communication may heal EB wounds
LONDON – Disrupting how microorganisms communicate with each other could potentially help heal chronic wounds in patients with epidermolysis...
Conference Coverage
Esophageal stricture signals urgent treatment in kids with butterfly skin
LONDON –
Conference Coverage
SCC survival remains poor in epidermolysis bullosa
LONDON – Median survival was 2.4 years in patients with generalized severe recessive dystrophic epidermolysis bullosa after a first diagnosis.